Daclatasvir/ribavirin/sofosbuvirLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1950卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36545-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：148 / 148

相关论文

共 50 条

[41] Daclatasvir/sofosbuvir/velpatasvirLack of efficacy : 3 case reports
Reactions Weekly, 2024, 2018 (1) : 156 - 156
[42] Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients
Nelson, Mark
Rubio, Rafael
Lazzarin, Adriano
Romanova, Svetlana
Luetkemeyer, Annie
Conway, Brian
Molina, Jean-Michel
Xu, Dong
Srinivasan, Subasree
Portsmouth, Simon
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2017, 37 (03): : 103 - 111
[43] Successful treatment of HBV, HCV, & HEV, with 12-week long use of tenofovir, sofosbuvir, daclatasvir, and ribavirin: A case report
Wahid, Braira
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (01) : 149 - 150
[44] Ribavirin/sofosbuvirPalpitations: case report
Reactions Weekly, 2018, 1711 (1) : 277 - 277
[45] Ribavirin/sofosbuvirAnaemia: case report
Reactions Weekly, 2015, 1553 (1) : 263 - 263
[46] Ribavirin/sofosbuvirAnaemia: case report
Reactions Weekly, 2017, 1678 (1) : 154 - 154
[47] Ribavirin/sofosbuvirPneumonia: case report
Reactions Weekly, 2018, 1702 (1) : 222 - 222
[48] Ribavirin/sofosbuvirHyperbilirubinaemia: case report
Reactions Weekly, 2016, 1628 (1) : 316 - 316
[49] Ribavirin/sofosbuvirAnaemia: case report
Reactions Weekly, 2016, 1631 (1) : 160 - 160
[50] Ribavirin/interferonPancytopenia: case report
Reactions Weekly, 2018, 1693 (1) : 440 - 440

← 1 2 3 4 5 →